**
The recent reshaping of the Interagency Autism Coordinating Committee (IACC) by Robert F. Kennedy Jr., the current Secretary of the US Department of Health and Human Services, has ignited significant debate within the autistic community and among public health advocates. The modifications have raised alarms about potential biases in autism research funding and the validity of its scientific recommendations. As this situation unfolds, it highlights the ongoing struggle between established science and controversial ideologies surrounding autism treatment and understanding.
Restructuring of the IACC Sparks Outrage
On 16 April 2025, Kennedy held a discussion regarding the findings of the Centers for Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network survey. Following this, in late January, he appointed a new cadre of members to the IACC, significantly altering its composition. Critics have pointed out that this new committee features a notable reduction in autistic representation, now only including a single autistic member, compared to seven prior members. This shift has raised concerns about the committee’s commitment to representing the voices and perspectives of those most affected by autism.
The IACC, while not widely known, plays a crucial role in advising the federal government on autism-related issues and managing nearly $2 billion in federal research funding. The committee is tasked with making recommendations on a range of topics, including education, social services, and healthcare. With its recent reconstitution, many argue that its ability to fulfil these functions ethically and effectively is in jeopardy.
Emergence of a Rival Organisation
In response to the reconfiguration of the IACC, a new body named the Independent Autism Coordinating Committee (I-ACC) was established on 3 March. This independent organisation aims to provide research recommendations grounded in scientific evidence, countering concerns that the federal committee might prioritise anti-vaccine rhetoric and debunked theories linking vaccines to autism. However, the I-ACC has faced its own scrutiny; it currently features only one autistic member and has been accused of advocating for a division within the autism spectrum, labelling certain cases as “profound autism,” a categorisation some members of the autistic community reject as unscientific.
Critics, including Zoe Gross, director of the Autistic Self Advocacy Network, have voiced their apprehensions about the potential implications of funding for research that aligns with outdated theories, which they argue could be detrimental not only to public health but also to the credibility of autism research.
Concerns Over Scientific Validity
The prior structure of the IACC allowed for a diverse array of voices, including those from marginalised communities. Many were hopeful that the continuity of such representation would ensure that autism research would be conducted ethically and effectively. However, with Kennedy’s overhaul, the committee has been labelled a “sham” by former member Matt Carey, who believes its configuration is designed to validate predetermined conclusions rather than foster genuine scientific inquiry.
The federal committee’s potential trajectory is troubling, especially as it echoes the controversial approaches taken during the previous Trump administration. The current administration’s representatives have voiced intentions to direct autism research into the 21st century, but as Gross cautions, this could lead to a waste of resources on disproven hypotheses, which could ultimately harm public health.
Future Directions for Autism Research
The I-ACC is in its infancy, and its founders are actively seeking to broaden its membership to include a more diverse representation of autistic individuals and advocates. David Mandell, a founding member of the I-ACC, acknowledges the importance of ensuring that all relevant perspectives are included in discussions about autism research. He expressed a desire for the committee to develop a focused research agenda that captures the complexity and diversity of the autism spectrum, aiming to present a well-supported case for funding high-quality scientific inquiry.
The independent committee is poised to carve out a space for evidence-based conversation, especially in an environment increasingly influenced by misinformation. Mandell emphasises that the groundwork for this initiative will be crucial, particularly as it prepares to assert its relevance in future funding discussions and policy-making.
Why it Matters
The ongoing discourse surrounding the restructuring of the IACC and the establishment of the I-ACC underscores a critical juncture in autism advocacy and research. As the stakes grow higher, the challenge lies in navigating the divide between scientific integrity and ideological agendas. The outcome of these developments will not only shape the future of autism research funding but will also significantly impact the lives of autistic individuals and their families, making it imperative for all voices to be heard in this essential conversation.
